DNLI
Denali Therapeutics Inc.
$17.98
+$0.61(+3.51%)
63
Overall
60
Value
75
Tech
55
Quality
Market Cap
$2.44B
Volume
1.40M
52W Range
$10.57 - $26.18
Target Price
$32.36
EPS Estimates Overview
| Current Quarter | $-0.76 | Next Quarter | $-0.78 |
| Current Year | $-3 | Next Year | $-3.1 |
| QoQ Growth | -2.6% | YoY Growth | -3.3% |
| 3Y EPS CAGR | -2.5% | Target Price | $32.36 |
| Consensus | Buy | Upside | +80.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $17.98 | +3.5% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW